Core Viewpoint - Eddie Pharmaceuticals announced the approval of a plan to use up to 100 million yuan of idle raised funds to temporarily supplement working capital, specifically for operations related to its main business [1] Group 1 - The third meeting of the third board of directors approved the fund usage [1] - The funds will be used for a period not exceeding 12 months from the date of board approval [1] - No shareholder meeting approval is required for this decision [1]

证券日报网讯2月12日，钱江摩托（000913）发布公告称，公司决定以自有资金75.97万元，按调整后 4.01元/股的价格回购注销6名激励对象已获授但尚未解锁的18.25万股限制性股票，回购完成后总股本将 由5.27亿股降至5.26亿股。 ...

Group 1 - The core point of the article is that Jiangyan Group (601065) reported its shareholder count as of February 10, 2026, which stands at 34,766 households [1]

证券日报网讯2月12日，领湃科技（300530）在互动平台回答投资者提问时表示，截至2026年2月10日， 公司股东总人数为17020户。 ...

Group 1 - The core point of the article is that Sely Medical (603716) reported a total of 76,776 shareholders as of February 10, 2026 [1]

证券日报网讯2月12日，唯科科技（301196）在互动平台回答投资者提问时表示，截至2026年2月10日， 公司股东总户数为15851户。 ...

Core Viewpoint - The company, Nichicon Technology, is actively expanding its X-ray detection technology applications across various industries, including integrated circuits, electronic manufacturing, new energy batteries, castings, welding materials, and food foreign object detection, with plans to further explore new application scenarios in biomedicine [1] Group 1 - The company's X-ray detection technology and products are widely used in multiple sectors [1] - There is a focus on expanding the coverage of the company's detection business [1] - New application scenarios, including biomedicine, are being targeted for future growth [1]

证券日报网讯2月12日，纵横股份在互动平台回答投资者提问时表示，2025年，随着国家及地方低空经 济相关规划的密集出台，无人机在智慧政务、巡检、应急救援、物流等领域的商业化应用快速落地。公 司核心产品与解决方案直接受益于市场需求的规模化放量，尤其在以"无人值守系统+纵横云+AI"形成 的低空AI数字化解决方案在国内多地开展应用示范，同时公司积极推进国内外重点项目交付验收，加 强成本费用控制，通过多措并举实现公司主营业务收入显著增长，净利润实现扭亏为盈。2026年，公司 将紧抓低空战略机遇，依托低空AI数字化解决方案，深化从"设备供应商"向"低空AI应用与运营"转型升 级，稳步提升公司经营质量及盈利能力。 ...

Core Viewpoint - The company is actively investing in and developing cellular RF front-end products, with related products entering mass production and expected to generate sales revenue by 2026, contributing to revenue growth [1] Group 1: Product Development - The company has begun to focus on cellular RF front-end products since its listing, with products already in the mass production stage [1] - The company is closely adapting to mainstream RedCap chip technologies from major chip manufacturers, which have matured significantly [1] - The company is increasing efforts in the research and development of RedCap RF front-end chips in collaboration with invested enterprises [1] Group 2: Market Opportunities - The company is exploring opportunities in the satellite communication RF front-end product sector and has initiated preliminary research [1] - The company is expected to benefit from advancements in main chip size, cost, battery life, and high-precision positioning [1]

Group 1 - The core point of the article is that Yiyi Co., Ltd. (stock code: 001206) reported a total of 19,061 shareholders holding its stock as of February 10, 2026 [1]